Literature DB >> 21714436

Coping strategies and adherence to treatment in patients with type 2 diabetes mellitus.

Ma Eugenia Garay-Sevilla1, José Santiago Porras, Juan Manuel Malacara.   

Abstract

INTRODUCTION: Diverse psychosocial and cultural factors are related to adherence to treatment of type 2 Diabetes mellitus (DM2) such as social support, coping styles and the cost of medical attention.
OBJECTIVE: To study the influence of diverse psychosocial factors on adherence to treatment in patients with DM2.
MATERIAL AND METHODS: In a cross sectional design we studied adherence to diet and medication, and its relationship with CS for diabetes, belief in conventional medicine, social support, and the perception of the burden of treatment cost on family finances.
RESULTS: We included 210 patients a mean age of 56.3 years, 9.4 years since diagnosis. Male DM patients had better adherence to medication (p<0.016) and social support (p<0.004), and higher rates for supportant CS (31.8 vs. 29.0; p<0.009). Adherence to diet was associated with belief in conventional medicine (p<0.035) and marginally related to fatalistic CS (p<0.05). After testing social security coverage as dummy variable, a marginal association was found (p<0.15). Adherence to medication was associated with supportant CS (p<0.02) and marginally with avoidant CS (p<0.05).
CONCLUSIONS: Supportant CS was more frequent in men. Belief in conventional medicine, and supportant CS were associated with adherence to treatment. These factors should be considered for a more rational approach for the management of disease.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21714436

Source DB:  PubMed          Journal:  Rev Invest Clin        ISSN: 0034-8376            Impact factor:   1.451


  8 in total

Review 1.  Understanding patients' adherence-related beliefs about medicines prescribed for long-term conditions: a meta-analytic review of the Necessity-Concerns Framework.

Authors:  Rob Horne; Sarah C E Chapman; Rhian Parham; Nick Freemantle; Alastair Forbes; Vanessa Cooper
Journal:  PLoS One       Date:  2013-12-02       Impact factor: 3.240

2.  Treatment adherence in patients with type 2 diabetes mellitus correlates with different coping styles, low perception of self-influence on disease, and depressive symptoms.

Authors:  Andrzej Kokoszka
Journal:  Patient Prefer Adherence       Date:  2017-03-17       Impact factor: 2.711

Review 3.  A systematic review of the relationships among psychosocial factors and coping in adults with type 2 diabetes mellitus.

Authors:  Melissa A McCoy; Laurie A Theeke
Journal:  Int J Nurs Sci       Date:  2019-09-06

4.  Type 2 diabetes self-management: spirituality, coping and responsibility.

Authors:  Natasha Duke
Journal:  J Res Nurs       Date:  2021-12-21

5.  Predictors of Diet-Induced Weight Loss in Overweight Adults with Type 2 Diabetes.

Authors:  Kirsten A Berk; Monique T Mulder; Adrie J M Verhoeven; Herman van Wietmarschen; Ruud Boessen; Linette P Pellis; Adriaan van T Spijker; Reinier Timman; Behiye Ozcan; Eric J G Sijbrands
Journal:  PLoS One       Date:  2016-08-05       Impact factor: 3.240

6.  Influence of Major Coping Strategies on Treatment Non-adherence and Severity of Comorbid Conditions in Hemodialysis Patients.

Authors:  Hyun Chan Hwang; Hye Ri Kim; Doug Hyun Han; Ji Sun Hong; So-Hee Jeong; Jung-Ho Shin; Su-Hyun Kim; Jin Ho Hwang; Sun Mi Kim
Journal:  J Korean Med Sci       Date:  2018-04-26       Impact factor: 2.153

7.  Continuity of care with physicians and risk of subsequent hospitalization and end-stage renal disease in newly diagnosed type 2 diabetes mellitus patients.

Authors:  Po-Ya Chang; Li-Nien Chien; Chyi-Huey Bai; Yuh-Feng Lin; Hung-Yi Chiou
Journal:  Ther Clin Risk Manag       Date:  2018-03-13       Impact factor: 2.423

8.  Nonadherence of Oral Antihyperglycemic Medication Will Increase Risk of End-Stage Renal Disease.

Authors:  Po-Ya Chang; Li-Nien Chien; Yuh-Feng Lin; Hung-Yi Chiou; Wen-Ta Chiu
Journal:  Medicine (Baltimore)       Date:  2015-11       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.